Access
To read this story in full you will need to login or make a payment (see right).
news feature
Nature 410, 622-625 (5 April 2001) | doi:10.1038/35070659
Open Innovation Challenges
-
Single-cell Analysis Platform
This Challenge is looking for novel approaches to analyzing changes at a single-cell level. This is...
-
Methods to Analyze Consumer Emotions
The Seeker is looking for methods to analyze consumer emotions. This Challenge requires only a writ...
- More Challenges
- Powered by:
nature jobs
Regional Sales Manager- Genrric Division (Copporate Office)
- Rhydburg Pharmaceuticals
- Selaqui-Dehradun India
One Postdoctoral Position at Centre for Research in Agricultural Genomics
- The Centre for Research Agricultural Genomics Consorcio CSIC-IRTA-UAB
- Barcelona Spain
Can they rebuild us?
Peter Aldhous1
Abstract
The idea of therapeutic cloning, which offers the potential of growing replacement tissues perfectly matched to their recipients, is falling from favour. But there are alternatives, as Peter Aldhous found out.
Take two of the biological breakthroughs of the late 1990s and combine them to produce a medical miracle — that is the thinking behind therapeutic cloning. The achievements are the cloning technology that in February 1997 gave us Dolly the sheep1, and the successful creation the following year of cultures of human embryonic stem (ES) cells2.
To read this story in full you will need to login or make a payment (see right).
